Skip to main content

Find Clinical Trials

Home
Conditions
Hemoglobinuria, Paroxysmal

Clinical trial condition

Hemoglobinuria, Paroxysmal

Explore clinical trials studying Hemoglobinuria, Paroxysmal. Study availability and eligibility vary by location and protocol.

159 public trials 28 recruiting studies

Refine in advanced search Browse all conditions

Hemoglobinuria, Paroxysmal trial results

Completed

First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers

NCT03316521

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +12 more
Locations: HighPoint Clinical Trials Center High Point, North Carolina, United States

View Trial Details

Completed

Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study

NCT01412047

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +6 more
Locations: University Park Hematology Oncology Englewood, Colorado, United States

Cleveland Clinic Florida Weston, Florida, United States

Maine Cancer Center of Medicine Scarborough, Maine, United States

Melbourne, Australia

View all 14 locations

View Trial Details

Completed

Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria

NCT00130000

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders

NCT00587054

Conditions: Allogeneic Stem Cell Transplant, Anemia, Anemia, Hemolytic, +18 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors

NCT00618969

Conditions: Anemia, Anemia, Aplastic, Anemia, Hemolytic, +26 more
Locations: Arizona Cancer Center/University Medical Center Tucson, Arizona, United States

View Trial Details

Completed

Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer

NCT00975975

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Anemia, +47 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome

NCT00731328

Conditions: Anemia, Anemia, Aplastic, Anemia, Hemolytic, +12 more
Locations: Asan Medical Center - University of Ulsan College of Medicine Seoul, South Korea

View Trial Details

Completed

Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes

NCT00004143

Conditions: Anemia, Anemia, Aplastic, Anemia, Hemolytic, +16 more
Locations: Florida Hospital Cancer Institute Orlando, Florida, United States

Duke Cancer Institute Durham, North Carolina, United States

View Trial Details

Completed

Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease

NCT01294891

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
Locations: Oregon Health & Science University Portland, Oregon, United States

View Trial Details

Completed

Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer

NCT00012376

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +46 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details